Screener
bioAffinity Technologies, Inc. BIAF Q4 2025 Annual earnings
Reported March 13, 2026 · After market close
Revenue$1.6MBeat by $39.0K
EPS-$1.11Beat by $1.59
Revenue estimate$1.6M
EPS estimate-$2.70
Next report
Nov 18, 2026 (in 2 months)Revenue estimate$1.9M
EPS estimate-$31.50
Versus estimates
Revenue
Diluted EPS
FAQ
- When did bioAffinity Technologies, Inc. report Q4 2025 earnings?
- bioAffinity Technologies, Inc. (BIAF) reported Q4 2025 earnings on March 13, 2026 after market close.
- What were bioAffinity Technologies, Inc.'s Q4 2025 revenue and EPS?
- bioAffinity Technologies, Inc. reported revenue of $1.6M and eps of $-1.11 for Q4 2025.
- Did bioAffinity Technologies, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $1.6M by $39.0K. EPS beat the consensus estimate of $-2.70 by $1.59.
- How did bioAffinity Technologies, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 27.9% from $2.2M a year earlier and eps declined 428.6% from $-0.21.
- Where can I find bioAffinity Technologies, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-009463) and the 10-K periodic report (0001493152-26-010143) directly on SEC EDGAR. The filing index links above go to sec.gov.
